Which has grown faster, BNTX or RMD?

Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus RMD at 12.08%.

Does BNTX or RMD pay a bigger dividend?

RMD pays a dividend (1.04% yield), while BNTX is a former payer with no current dividend run rate.

Is BNTX or RMD more profitable?

RMD runs the higher net margin — BNTX at -62.98% versus RMD at 26.94%.

How have BNTX and RMD total returns compared?

Over the past 5 years, BNTX delivered -19.46% and RMD delivered 13.95% annualized total return. Past performance doesn't predict future results.

BioNTech SE (BNTX) vs ResMed Inc. (RMD)

A side-by-side comparison of BioNTech SE and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

BNTX

BioNTech SE

$29.28B

$116.57HealthcareAt close: Aug 21, 2026, 4:00 PM ET

RMD

ResMed Inc.

$33.58B

$231.52HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — BNTX vs RMD

growth of $100 · dividends reinvested · last 7y

BNTX +729.5% (+35.3%/yr)RMD +86.5% (+9.3%/yr)BNTX compounded faster over this window

BNTX RMD

BNTX vs RMD: by the numbers

•RMD is the larger company ($33.58B vs $29.28B market cap).
•RMD is profitable (26.94% net margin) while BNTX runs a net loss (-62.98%).
•BNTX grew revenue faster over the past five years (40.61% vs 12.08% CAGR).
•RMD pays a dividend (1.04% yield), while BNTX is a former payer with no current dividend run rate.

Metrics side by side

Valuation

Metric	BNTX	RMD
P/E ratio	N/A	22.26
Forward P/E	N/A	20.81
P/S ratio	9.53	5.94
P/B ratio	1.46	5.10
EV / EBITDA	N/A	15.75
FCF yield	2.10%	8.61%

Profitability

Metric	BNTX	RMD
Gross margin	70.98%	61.16%
Operating margin	-22.63%	33.48%
Net margin	-62.98%	26.94%
ROE	-9.62%	23.13%
ROIC	-10.37%	19.18%

Dividends

Metric	BNTX	RMD
Dividend yield	N/A	1.04%
Payout ratio	N/A	22.99%

Growth (annualized)

Metric	BNTX	RMD
Revenue CAGR (5Y)	40.61%	12.08%
EPS CAGR (5Y)	N/A	26.14%
FCF CAGR (5Y)	N/A	36.06%
Total return CAGR (5Y)	-19.46%	-3.24%

Frequently asked

Which has grown faster, BNTX or RMD?: Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus RMD at 12.08%.
Does BNTX or RMD pay a bigger dividend?: RMD pays a dividend (1.04% yield), while BNTX is a former payer with no current dividend run rate.
Is BNTX or RMD more profitable?: RMD runs the higher net margin — BNTX at -62.98% versus RMD at 26.94%.
How have BNTX and RMD total returns compared?: Over the past 5 years, BNTX delivered -19.46% and RMD delivered 13.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BNTX analysis Full RMD analysis Interactive comparison tool

Dig into the metrics

ResMed P/E ratio ResMed dividend yield BioNTech SE ROE ResMed ROE BioNTech SE operating margin ResMed operating margin BioNTech SE revenue growth ResMed revenue growth BioNTech SE free cash flow ResMed free cash flow

BioNTech SE & ResMed appear in these rankings

Fastest Revenue Growth Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.